Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr

New Delhi [India], May 30: Gujarat-based Aristo Bio-Tech and Lifescience Ltd, a fast-growing company in the agrochemical and biotechnology space, has reported a stellar financial performance for the fourth quarter and full financial year ended March 31, 2025 (FY25). The company posted a strong turnaround in profitability, with significant growth in revenue. Due to expansion [...]

PNN
PNN Verified Media or Organization • 16 Apr, 2026 Agency
May 31, 2025 • 1:48 PM
B
Business
NEWS CARD
Logo
Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr
“Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr”
Favicon
Read more on en.sangritimes.com
31 May 2025
https://en.sangritimes.com/aristo-bio-tech-fy25-pat-rises-to-rs-406-cr-revenue-jumps-30-percent-to-rs-31809-cr
Copied
Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr
Aristo Bio-Tech FY25 PAT Rises to Rs 4.06 Cr, Revenue Jumps 30 Percent to Rs 318.09 Cr

New Delhi [India], May 30: Gujarat-based Aristo Bio-Tech and Lifescience Ltd, a fast-growing company in the agrochemical and biotechnology space, has reported a stellar financial performance for the fourth quarter and full financial year ended March 31, 2025 (FY25). The company posted a strong turnaround in profitability, with significant growth in revenue. Due to expansion and increased capital expenditure, depreciation has risen by Rs. 1 crore compared to last year, resulting in a lower visible profit.

Key Highlights: (in crores)

PNN Verified Media or Organization • 16 Apr, 2026 Agency

PNN is a press-release and corporate-communications distribution service. Content under this byline is sponsored / press-release material provided by third parties and does not reflect the editorial opinion of Sangri Times.

home Home amp_stories Web Stories local_fire_department Trending play_circle Videos mark_email_unread Newsletter